KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Total Debt (2017 - 2026)

ClearPoint Neuro's Total Debt history spans 13 years, with the latest figure at $49.1 million for Q4 2025.

  • On a quarterly basis, Total Debt changed N/A to $49.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.1 million, a N/A change, with the full-year FY2025 number at $49.1 million, changed N/A from a year prior.
  • Total Debt hit $49.1 million in Q4 2025 for ClearPoint Neuro, up from $29.2 million in the prior quarter.
  • Over the last five years, Total Debt for CLPT hit a ceiling of $49.1 million in Q4 2025 and a floor of $9.8 million in Q4 2021.
  • Historically, Total Debt has averaged $17.1 million across 4 years, with a median of $9.9 million in 2023.
  • The widest YoY moves for Total Debt: up 1865.74% in 2021, down 60.65% in 2021.
  • Tracing CLPT's Total Debt over 4 years: stood at $9.8 million in 2021, then increased by 0.56% to $9.9 million in 2022, then rose by 0.57% to $9.9 million in 2023, then soared by 393.29% to $49.1 million in 2025.
  • Business Quant data shows Total Debt for CLPT at $49.1 million in Q4 2025, $29.2 million in Q3 2025, and $28.8 million in Q2 2025.